AstraZeneca and Forest Laboratories to initiate phase III clinical trials for ceftazidime/avibactam
ceftazidime/avibactam (CAZ-AVI) will enter phase III trials...
18 October 2011 | By AstraZeneca
ceftazidime/avibactam (CAZ-AVI) will enter phase III trials...